Boston Scientific Corporation Share Price

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 21:00:01 16/04/2024 BST 5-day change 1st Jan Change
68.12 USD +1.01% Intraday chart for Boston Scientific Corporation -0.79% +17.83%
Sales 2024 * 15.58B 1,252B Sales 2025 * 17.03B 1,369B Capitalization 99.13B 7,968B
Net income 2024 * 2.05B 165B Net income 2025 * 2.58B 208B EV / Sales 2024 * 6.74 x
Net Debt 2024 * 5.82B 468B Net Debt 2025 * 2.66B 214B EV / Sales 2025 * 5.98 x
P/E ratio 2024 *
48.7 x
P/E ratio 2025 *
39.2 x
Employees 48,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.64%
More Fundamentals * Assessed data
Dynamic Chart
Integer Holdings to Benefit from Pulsed Field Ablation Market Growth, BofA Says MT
Truist Securities Adjusts Boston Scientific Price Target to $79 From $73, Buy Rating Kept MT
BTIG Adjusts Boston Scientific's Price Target to $74 From $72 MT
RBC Raises Price Target on Boston Scientific to $78 From $70, Keeps Outperform Rating MT
Penumbra, Inc. : The underdog in healthcare Our Logo
Nectero Medical LLC announced that it has received $96 million in funding from Boston Scientific Corporation, NVP Associates, LLC, BioStar Ventures LLC, Cadence Healthcare Ventures, Llc, Aphelion Capital, LLC and other investors CI
Boston Scientific Starts Study of Software Module, Catheter for Treatment of Atrial Fibrillation MT
Boston Scientific, Axonics Receive FTC Second Request on Merger Deal MT
Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information DJ
FTC seeks additional information for Boston Scientific's $3.7 bln Axonics deal RE
Argus Raises Boston Scientific's Price Target to $80 From $69, Keeps Buy Rating MT
Citigroup Adjusts Price Target on Boston Scientific to $79 From $71, Keeps Buy Rating MT
Boston Scientific Insider Sold Shares Worth $1,133,069, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $477,777, According to a Recent SEC Filing MT
Scivita Medical Technology Co., Ltd. and Boston Scientific Corporation Sign an Expanded Strategic Cooperation Arrangement CI
More news
1 day+0.89%
1 week-1.15%
Current month-0.91%
1 month+0.94%
3 months+12.65%
6 months+35.47%
Current year+17.40%
More quotes
1 week
67.37
Extreme 67.37
69.21
1 month
66.16
Extreme 66.16
69.21
Current year
57.11
Extreme 57.11
69.21
1 year
48.35
Extreme 48.35
69.21
3 years
34.98
Extreme 34.98
69.21
5 years
24.10
Extreme 24.1
69.21
10 years
11.10
Extreme 11.1
69.21
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 16/10/11
Director of Finance/CFO 58 30/11/96
Chief Tech/Sci/R&D Officer - 31/08/09
Members of the board TitleAgeSince
Director/Board Member 61 22/06/21
Director/Board Member 69 31/03/15
Director/Board Member 72 28/02/14
More insiders
Date Price Change Volume
16/04/24 68.12 +1.01% 6,619,233
15/04/24 67.44 -0.93% 6,527,104
12/04/24 68.07 -1.12% 4,995,155
11/04/24 68.84 +0.28% 6,439,168
10/04/24 68.65 -0.01% 5,200,008

Delayed Quote Nyse, April 16, 2024 at 04:00 pm

More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
67.44 USD
Average target price
73.11 USD
Spread / Average Target
+8.41%
Consensus